VKH
AERI

Virtu KCG Holdings’s Aerie Pharmaceuticals AERI Stock Holding History

Virtu KCG Holdings’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$284K Buy
+5,412
New +$252K 0.01% 1739
2016
Q4 		– Sell
-6,361
Closed -$240K – 3923
2016
Q3 		$240K Buy
+6,361
New +$140K 0.01% 2174
2015
Q4 		– Sell
-13,468
Closed -$239K – 4057
2015
Q3 		$239K Buy
+13,468
New +$244K ﹤0.01% 2368

Other funds holding AERI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Virtu KCG Holdings's AERI Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Aerie Pharmaceuticals (AERI) in Q2 2017: 5,412 shares worth $284K. The stake represents 0.01% of the portfolio and ranks #1739 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in AERI as recently as Q3 2016.

Virtu KCG Holdings first reported a position in AERI in Q3 2015 and has held it in 3 quarters since. 172 funds tracked by Wall St. Rank hold AERI as of Q2 2017.

  • Virtu KCG Holdings held 5,412 shares of Aerie Pharmaceuticals worth $284K as of Q2 2017.
  • Aerie Pharmaceuticals was a new Virtu KCG Holdings position in Q2 2017.
  • Aerie Pharmaceuticals made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1739 holding.
  • Virtu KCG Holdings first reported a position in Aerie Pharmaceuticals in Q3 2015 and has held it in 3 quarters since.
  • 172 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.